Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Akkermansia muciniphila: a potential booster to improve the effectiveness of cancer immunotherapy
Shiying Fan, Zhengting Jiang, Zhilin Zhang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 14, pp. 13477-13494
Closed Access | Times Cited: 11

Showing 11 citing articles:

Increasing spatial working memory in mice with Akkermansia muciniphila
Ji‐Seon Ahn, Sura Kim, Eui-Jeong Han, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Dynamic Changes of the Gut Microbiota and Its Functional Metagenomic Potential during the Development of Non-Small Cell Lung Cancer
Cuijiao Feng, Na Li, Guangqi Gao, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3768-3768
Open Access | Times Cited: 8
Bones and guts – Why the microbiome matters
Kelly F. Contino, Katherine L. Cook, Yusuke Shiozawa
Journal of bone oncology (2024) Vol. 44, pp. 100523-100523
Open Access | Times Cited: 4
Inhibition of inosine metabolism of the gut microbiota decreases testosterone secretion in the testis
Lei Tang, Xizhong Yang, Mengting Zhou, et al.
mSystems (2024) Vol. 9, Iss. 4
Open Access | Times Cited: 4
Gut microbial predictors of first-line immunotherapy efficacy in advanced NSCLC patients
Anna Grenda, Ewelina Iwan, Barbara Kuźnar-Kamińska, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The role of Akkermansia muciniphila in cancer: Mechanisms, therapeutic potential, and challenges
Xi Chen, Li Yao, Guoli Wei, et al.
iMetaOmics. (2025)
Open Access
Gut microbiota alteration - Cancer relationships and synbiotic roles in cancer therapies
Adekunle Babajide Rowaiye, Gordon C. Ibeanu, Doofan Bur, et al.
The Microbe (2024) Vol. 4, pp. 100096-100096
Open Access | Times Cited: 3
Novel pectin-carboxymethylcellulose-based double-layered mucin/chitosan microcomposites successfully protect the next-generation probiotic Akkermansia muciniphila through simulated gastrointestinal transit and alters microbial communities within colonic ex vivo bioreactors
Linh Phuong Ta, Sarah Corrigan, Richard D. Horniblow
International Journal of Pharmaceutics (2024) Vol. 665, pp. 124670-124670
Open Access | Times Cited: 1
Akkermansia muciniphila activates natural killer cells by suppressing the TGF-β signaling pathway in lung adenocarcinoma cells
Yong Li, Huiqin Huang, Hang Xie, et al.
Cytokine (2024) Vol. 186, pp. 156833-156833
Closed Access | Times Cited: 1
New Metabolomic Insights Into Cancer
Jiangjiang Zhu
The Cancer Journal (2024) Vol. 30, Iss. 5, pp. 301-306
Closed Access
Lifestyle Medicine Coaching in Patients with Cancer: A Case Study
Minako Abe, Hiroyuki Abe
Personalized Medicine Universe (2024) Vol. 13, pp. 50-53
Open Access
Page 1

Scroll to top